Basic information Synthesis Description Reference Safety Supplier Related
ChemicalBook >  Product Catalog >  Pharmaceutical intermediates >  Heterocyclic compound >  Isoquinoline compounds >  1,2,3,4-TETRAHYDROISOQUINOLINE

1,2,3,4-TETRAHYDROISOQUINOLINE

Basic information Synthesis Description Reference Safety Supplier Related

1,2,3,4-TETRAHYDROISOQUINOLINE Basic information

Product Name:
1,2,3,4-TETRAHYDROISOQUINOLINE
Synonyms:
  • 1,2,3,4-Tetrahydro-2-azanaphthalene
  • 1,2,3,4-Tetrahydro-2-isoquinoline
  • 1,2,3,4-tetrahydro-isoquinolin
  • Tetrahydroisoquinoline
  • LABOTEST-BB LTBB000776
  • AKOS BB-9293
  • 1,2,3,4-TETRAHYDROISOQUINOLINE
  • 1,2,3,4-Tetrahydro-#niso-quinoline
CAS:
91-21-4
MF:
C9H11N
MW:
133.19
EINECS:
202-050-0
Product Categories:
  • Bioactive Small Molecules
  • Building Blocks
  • Cell Biology
  • Chemical Synthesis
  • Heterocyclic Building Blocks
  • T
  • Quinoline&Isoquinoline
  • Building Blocks
  • Heterocyclic Building Blocks
  • Isoquinolines
  • bc0001
Mol File:
91-21-4.mol
More
Less

1,2,3,4-TETRAHYDROISOQUINOLINE Chemical Properties

Melting point:
−30 °C(lit.)
Boiling point:
232-233 °C(lit.)
Density 
1.064 g/mL at 25 °C(lit.)
vapor pressure 
3.33-97.9Pa at 20-58.5℃
refractive index 
n20/D 1.568(lit.)
Flash point:
210 °F
storage temp. 
Keep in dark place,Sealed in dry,Room Temperature
solubility 
20g/l
form 
Liquid
pka
9.66±0.20(Predicted)
color 
Clear yellow to brown
Water Solubility 
Soluble in water at 20°C 20g/L.
BRN 
116156
InChIKey
UWYZHKAOTLEWKK-UHFFFAOYSA-N
CAS DataBase Reference
91-21-4(CAS DataBase Reference)
EPA Substance Registry System
Isoquinoline, 1,2,3,4-tetrahydro- (91-21-4)
More
Less

Safety Information

Hazard Codes 
Xi
Risk Statements 
36/37/38
Safety Statements 
26-36
WGK Germany 
3
RTECS 
NX4900000
Hazard Note 
Irritant
TSCA 
Yes
HS Code 
29334900

MSDS

More
Less

1,2,3,4-TETRAHYDROISOQUINOLINE Usage And Synthesis

Synthesis

To a solution of the isoquinolinone (1.156 g, 9.90 mmol) and tert-butyl alcohol (0.88 mL, 11.9 mmol) in THF (30 mL) at −78 °C was added liquid ammonia (about 280 mL). Lithium was added in small pieces until the blue coloration persisted, after which the solution was stirred at −78 °C for 30 min. The blue coloration was dissipated with piperlyne, 4-methoxybenzyl chloride (4.83 g, 31.00 mmol) in THF (5 mL) was introduced by syringe, and the mixture was stirred for an additional 150 min at −78 °C. Solid ammonium chloride was added and then the ammonia was allowed to evaporate. The pale yellow residue was partitioned between CH2Cl2 (30 mL) and water (40 mL). The layers were separated, and the aqueous layer was extracted with CH2Cl2 (2 × 30 mL). The combined organic layers were washed with 10% sodium thiosulfate solution (20 mL), dried over magnesium sulfate, and concentrated. Flash chromatography (EtOAc:hexane, 2:1) on silica gave 2.21 g (75%) of the tetrahydroisoquinolinone.  
Reference: Schultz, A. G.; Guzi, T. J.; Larsson, E.; Rahm, R.; Thakker, K. Bidlack, J. M. J. Org. Chem. 1998, 63, 7795–7804.

Description

1, 2, 3, 4-TETRAHYDROISOQUINOLINE belongs to tetrahydroisoquinoline compound, which is encountered in a number of drugs, tubocurarine, one of the quaternary ammonium muscle relaxants1-3. It is used as a reagent in the preparation of4-(1, 2, 4-oxadiazol-5-yl) piperidine-1-carboxamides as antiproliferative tubulin inhibitors1. It can be used for the synthesis of 1, 2, 3, 4-tetrahydroisoquinoline-3-carboxylic acid (Tic), which has strong applications in peptides and peptidomimetics design and discovery2. 1, 2, 3, 4-tetrahydroisoquinoline has been made into some derivatives with potential for prevention of parkinsonism4, cancer treatment5 and acting as Anticonvulsant Agents6.

Reference

  1. https://www.alfa.com/en/catalog/L08143/
  2. https://www.ncbi.nlm.nih.gov/pubmed/21235510
  3. https://en.wikipedia.org/wiki/Tetrahydroisoquinoline
  4. Okuda, K, Y. Kotake, and S. Ohta. "Parkinsonism-preventing activity of 1-methyl-1, 2, 3, 4-tetrahydroisoquinoline derivatives in C57BL mouse in vivo. Biological & Pharmaceutical Bulletin 29.7(2006):1401-1403.
  5. Luca, Laura De, et al. "3D Pharmacophore Models for 1, 2, 3, 4‐Tetrahydroisoquinoline Derivatives Acting as Anticonvulsant Agents." Archiv Der Pharmazie 339.7(2006):388-400.
  6. Hatano, H, et al. "Tumor-specific cytotoxic activity of 1, 2, 3, 4-tetrahydroisoquinoline derivatives against human oral squamous cell carcinoma cell lines."Anticancer Research 29.8(2009):3079-3086.

Chemical Properties

clear yellow to brown liquid

Uses

1,2,3,4-Tetrahydroisoquinoline is used as a reagent in the preparation of 4-(1,2,4-oxadiazol-5-yl)piperidine-1-carboxamides as antiproliferative tubulin inhibitors.

Definition

ChEBI: 1,2,3,4-tetrahydroisoquinoline is a member of isoquinolines.

Synthesis Reference(s)

The Journal of Organic Chemistry, 40, p. 1191, 1975 DOI: 10.1021/jo00897a001
Tetrahedron Letters, 26, p. 4633, 1985 DOI: 10.1016/S0040-4039(00)98771-9

1,2,3,4-TETRAHYDROISOQUINOLINESupplier

Shanghai Shinso-pharm Technology Co., Ltd. Gold
Tel
021-62165619 13917231399
Email
sales@shinso-pharm.com.cn
Anhui Qiushi Medical Technology Co., Ltd Gold
Tel
15005516438
Email
sales1@qiushipharm.com
J & K SCIENTIFIC LTD.
Tel
010-82848833 400-666-7788
Email
jkinfo@jkchemical.com
Meryer (Shanghai) Chemical Technology Co., Ltd.
Tel
4006608290; 18621169109
Email
market03@meryer.com
3B Pharmachem (Wuhan) International Co.,Ltd.
Tel
821-50328103-801 18930552037
Email
3bsc@sina.com